Avenue Therapeutics Stock Price History
| ATXI Stock | USD 2.06 0.02 0.98% |
Below is the normalized historical share price chart for Avenue Therapeutics extending back to June 27, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Avenue Therapeutics stands at 2.06, as last reported on the 28th of November, with the highest price reaching 2.06 and the lowest price hitting 2.04 during the day.
If you're considering investing in Avenue Stock, it is important to understand the factors that can impact its price. Avenue Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0538, which signifies that the company had a -0.0538% return per unit of standard deviation over the last 3 months. Avenue Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Avenue Therapeutics' mean deviation of 3.27, and Risk Adjusted Performance of (0.06) to double-check the risk estimate we provide.
As of now, Avenue Therapeutics' Total Stockholder Equity is increasing as compared to previous years. The Avenue Therapeutics' current Stock Based Compensation is estimated to increase to about 923.3 K, while Common Stock Total Equity is projected to decrease to 1,467. . As of now, Avenue Therapeutics' Price Book Value Ratio is increasing as compared to previous years. The Avenue Therapeutics' current Price To Book Ratio is estimated to increase to 1.13, while Price Earnings Ratio is projected to decrease to (0.17). Avenue Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of June 2017 | 200 Day MA 5.1021 | 50 Day MA 2.1934 | Beta (0.18) |
Avenue |
Sharpe Ratio = -0.0538
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ATXI |
Estimated Market Risk
| 4.41 actual daily | 39 61% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Avenue Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avenue Therapeutics by adding Avenue Therapeutics to a well-diversified portfolio.
Price Book 1.4942 | Book Value 4.635 | Enterprise Value 1.3 M | Enterprise Value Ebitda (0.42) | Shares Float 1.3 M |
Avenue Therapeutics Stock Price History Chart
There are several ways to analyze Avenue Stock price data. The simplest method is using a basic Avenue candlestick price chart, which shows Avenue Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 9, 2024 | 3.02 |
| Lowest Price | November 14, 2024 | 1.88 |
Avenue Therapeutics November 28, 2024 Stock Price Synopsis
Various analyses of Avenue Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Avenue Stock. It can be used to describe the percentage change in the price of Avenue Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Avenue Stock.| Avenue Therapeutics Price Daily Balance Of Power | 1.00 | |
| Avenue Therapeutics Price Action Indicator | 0.02 | |
| Avenue Therapeutics Price Rate Of Daily Change | 1.01 |
Avenue Therapeutics November 28, 2024 Stock Price Analysis
Avenue Stock Price History Data
The price series of Avenue Therapeutics for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 1.14 with a coefficient of variation of 13.52. The prices are distributed with arithmetic mean of 2.32. The median price for the last 90 days is 2.24. The company had 1:75 stock split on 26th of April 2024.| Open | High | Low | Close | Volume | ||
11/28/2024 | 2.04 | 2.06 | 2.04 | 2.06 | ||
| 11/27/2024 | 2.00 | 2.09 | 2.00 | 2.06 | 21,482 | |
| 11/26/2024 | 2.06 | 2.15 | 2.02 | 2.04 | 14,650 | |
| 11/25/2024 | 2.09 | 2.12 | 2.07 | 2.08 | 8,216 | |
| 11/22/2024 | 2.03 | 2.10 | 2.00 | 2.01 | 46,189 | |
| 11/21/2024 | 1.95 | 2.06 | 1.95 | 2.01 | 6,630 | |
| 11/20/2024 | 2.02 | 2.05 | 1.95 | 2.01 | 19,286 | |
| 11/19/2024 | 1.94 | 1.97 | 1.90 | 1.97 | 18,435 | |
| 11/18/2024 | 1.89 | 1.96 | 1.89 | 1.90 | 15,358 | |
| 11/15/2024 | 1.86 | 2.06 | 1.60 | 1.93 | 106,414 | |
| 11/14/2024 | 1.95 | 1.99 | 1.80 | 1.88 | 15,087 | |
| 11/13/2024 | 2.08 | 2.08 | 1.95 | 1.95 | 20,712 | |
| 11/12/2024 | 2.00 | 2.09 | 1.98 | 2.04 | 16,665 | |
| 11/11/2024 | 2.10 | 2.15 | 1.97 | 2.00 | 67,257 | |
| 11/08/2024 | 2.36 | 2.41 | 2.18 | 2.19 | 29,567 | |
| 11/07/2024 | 2.26 | 2.29 | 2.19 | 2.29 | 8,583 | |
| 11/06/2024 | 2.25 | 2.33 | 2.24 | 2.24 | 21,471 | |
| 11/05/2024 | 2.24 | 2.33 | 2.20 | 2.22 | 27,762 | |
| 11/04/2024 | 2.21 | 2.45 | 2.15 | 2.20 | 48,018 | |
| 11/01/2024 | 2.42 | 2.48 | 2.18 | 2.24 | 101,670 | |
| 10/31/2024 | 2.46 | 2.49 | 2.38 | 2.40 | 50,731 | |
| 10/30/2024 | 2.55 | 2.55 | 2.36 | 2.40 | 41,982 | |
| 10/29/2024 | 2.47 | 2.57 | 2.41 | 2.45 | 63,166 | |
| 10/28/2024 | 2.35 | 2.63 | 2.20 | 2.52 | 223,686 | |
| 10/25/2024 | 2.14 | 2.29 | 2.02 | 2.20 | 139,568 | |
| 10/24/2024 | 2.09 | 2.14 | 2.00 | 2.02 | 31,663 | |
| 10/23/2024 | 2.05 | 2.15 | 2.01 | 2.10 | 18,677 | |
| 10/22/2024 | 2.00 | 2.11 | 1.94 | 2.11 | 39,665 | |
| 10/21/2024 | 2.60 | 2.70 | 1.94 | 2.00 | 504,718 | |
| 10/18/2024 | 2.01 | 2.17 | 1.99 | 2.11 | 26,697 | |
| 10/17/2024 | 2.18 | 2.41 | 1.70 | 1.99 | 174,964 | |
| 10/16/2024 | 2.12 | 2.26 | 2.12 | 2.12 | 54,573 | |
| 10/15/2024 | 2.07 | 2.17 | 1.89 | 2.09 | 84,010 | |
| 10/14/2024 | 2.09 | 2.09 | 2.00 | 2.03 | 13,214 | |
| 10/11/2024 | 1.99 | 2.07 | 1.92 | 2.06 | 6,920 | |
| 10/10/2024 | 2.01 | 2.10 | 1.91 | 2.02 | 28,356 | |
| 10/09/2024 | 1.98 | 2.08 | 1.97 | 1.98 | 13,049 | |
| 10/08/2024 | 2.00 | 2.10 | 1.94 | 1.97 | 36,037 | |
| 10/07/2024 | 2.10 | 2.29 | 1.90 | 1.98 | 42,818 | |
| 10/04/2024 | 2.30 | 2.40 | 2.07 | 2.08 | 19,937 | |
| 10/03/2024 | 2.40 | 2.47 | 2.30 | 2.32 | 14,407 | |
| 10/02/2024 | 2.44 | 2.46 | 2.35 | 2.42 | 9,339 | |
| 10/01/2024 | 2.42 | 2.52 | 2.40 | 2.40 | 11,243 | |
| 09/30/2024 | 2.50 | 2.55 | 2.46 | 2.49 | 18,804 | |
| 09/27/2024 | 2.31 | 2.51 | 2.31 | 2.51 | 20,442 | |
| 09/26/2024 | 2.30 | 2.38 | 2.30 | 2.35 | 10,512 | |
| 09/25/2024 | 2.34 | 2.46 | 2.21 | 2.24 | 102,257 | |
| 09/24/2024 | 2.50 | 2.59 | 2.21 | 2.25 | 37,490 | |
| 09/23/2024 | 2.56 | 2.56 | 2.38 | 2.39 | 11,836 | |
| 09/20/2024 | 2.76 | 2.76 | 2.42 | 2.46 | 24,368 | |
| 09/19/2024 | 2.75 | 2.75 | 2.60 | 2.61 | 12,014 | |
| 09/18/2024 | 2.80 | 2.90 | 2.64 | 2.70 | 22,862 | |
| 09/17/2024 | 2.82 | 2.82 | 2.75 | 2.76 | 4,498 | |
| 09/16/2024 | 2.58 | 2.93 | 2.57 | 2.79 | 20,398 | |
| 09/13/2024 | 2.85 | 2.89 | 2.72 | 2.81 | 6,894 | |
| 09/12/2024 | 3.22 | 3.22 | 2.62 | 2.80 | 20,345 | |
| 09/11/2024 | 3.02 | 3.03 | 2.85 | 2.90 | 12,187 | |
| 09/10/2024 | 3.04 | 3.10 | 2.85 | 2.86 | 23,483 | |
| 09/09/2024 | 2.83 | 3.54 | 2.83 | 3.02 | 118,618 | |
| 09/06/2024 | 2.86 | 2.87 | 2.77 | 2.83 | 12,159 | |
| 09/05/2024 | 2.82 | 2.90 | 2.77 | 2.80 | 25,915 |
About Avenue Therapeutics Stock history
Avenue Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Avenue is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Avenue Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Avenue Therapeutics stock prices may prove useful in developing a viable investing in Avenue Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 141.2 K | 134.2 K | |
| Net Loss | -3.4 M | -3.5 M |
Avenue Therapeutics Stock Technical Analysis
Avenue Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Avenue Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Avenue Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Avenue Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Avenue to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (1.08) | |||
| Treynor Ratio | 3.77 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Avenue Stock analysis
When running Avenue Therapeutics' price analysis, check to measure Avenue Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avenue Therapeutics is operating at the current time. Most of Avenue Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avenue Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avenue Therapeutics' price. Additionally, you may evaluate how the addition of Avenue Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |